The Board of Directors of Vera Salus Ricerca has voted in favour of the incorporation of FlavOncology in Switzerland with a dedicated, strong executive team comprising a mix of local entrepreneurs and key figures from the company’s shareholders.

The Board of Directors of Vera Salus Ricerca has voted in favour of the incorporation of FlavOncology in Switzerland with a dedicated, strong executive team comprising a mix of local entrepreneurs and key figures from the company’s shareholders.

The management of Vera Salus Ricerca Srl (VSR) has decided unanimously to continue FlavOncology’s development in Switzerland, recognizing the fertile...

Read More
Vera Salus Ricerca has successfully completed a 1-year training at BioArk (Switzerland) aimed at polishing the business developmental plans of FlavOncology, its proprietary drug platform for the cure of cancer patients.

Vera Salus Ricerca has successfully completed a 1-year training at BioArk (Switzerland) aimed at polishing the business developmental plans of FlavOncology, its proprietary drug platform for the cure of cancer patients.

During 2020, Vera Salus Ricerca Srl (VSR) has performed a Pre-incubation Program at BioArk (Valais, Switzerland) sponsored by the Ark...

Read More